Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

Eligibility Criteria

• 1. Age 18-years-old or older
• 2. Identifies as Black or African American, by either chart documentation or participant self-report. Mixed-race including Black or African American is included.
• 3. Metastatic prostate cancer, by either chart documentation or participant self-report. Pathology report not needed.
• 4. Able to understand study procedures and to comply with them for the entire length of the study.
• 5. Able to understand a written information sheet and willing to verbally consent.
• 6. Fluent in English (reading, writing, and speaking)
• 1. Age 18-years-old or older
• 2. Identifies as Black or African-American, by either chart documentation or participant self-report. Mixed-race including Black or African-American is included.
• 3. Metastatic prostate cancer, by either chart documentation or participant self-report. Pathology report not needed.
• 4. Able to understand study procedures and to comply with them for the entire length of the study.
• 5. Fluent in English (reading, writing, and speaking).
• 6. Anticipated discussion of TGT within 0-90 days of enrollment, per treating oncology provider's discretion. TGT involves use of any cancer genetic sequencing (whether standard-of-care or part of a research protocol) via any one of the following:
• 1. Somatic DNA testing of already-collected tissue.
• 2. Somatic DNA testing of tissue to be collected in the future via biopsy, surgery, or other procedure.
• 3. Blood-based DNA testing to evaluate for circulating tumor DNA.
• 7. Able to understand a written informed consent document and willing to sign it.